(Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of recommending that COVID-19 vaccines for 2025-26 should target newer strains of the JN.1 variant.
(Reporting by Puyaan Singh in Bengaluru; Editing by Mohammed Safi Shamsi)
Brought to you by www.srnnews.com
